In Vitro and In Vivo Nutraceutical Characterization of Two Chickpea Accessions: Differential Effects on Hepatic Lipid Over-Accumulation.
ROS
hepatic steatosis
legumes
lipid dyshomeostasis
liver
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
24 Mar 2020
24 Mar 2020
Historique:
received:
28
02
2020
revised:
20
03
2020
accepted:
22
03
2020
entrez:
28
3
2020
pubmed:
28
3
2020
medline:
28
3
2020
Statut:
epublish
Résumé
Dietary habits are crucially important to prevent the development of lifestyle-associated diseases. Diets supplemented with chickpeas have numerous benefits and are known to improve body fat composition. The present study was undertaken to characterize two genetically and phenotypically distinct accessions, MG_13 and PI358934, selected from a global chickpea collection. Rat hepatoma FaO cells treated with a mixture of free fatty acids (FFAs) (O/P) were used as an in vitro model of hepatic steatosis. In parallel, a high-fat diet (HFD) animal model was also established. In vitro and in vivo studies revealed that both chickpea accessions showed a significant antioxidant ability. However, only MG_13 reduced the lipid over-accumulation in steatotic FaO cells and in the liver of HFD fed mice. Moreover, mice fed with HFD + MG_13 displayed a lower level of glycemia and aspartate aminotransferase (AST) than HFD mice. Interestingly, exposure to MG_13 prevented the phosphorylation of the inflammatory nuclear factor kappa beta (NF-kB) which is upregulated during HFD and known to be linked to obesity. To conclude, the comparison of the two distinct chickpea accessions revealed a beneficial effect only for the MG_13. These findings highlight the importance of studies addressing the functional characterization of chickpea biodiversity and nutraceutical properties.
Identifiants
pubmed: 32214012
pii: antiox9030268
doi: 10.3390/antiox9030268
pmc: PMC7139887
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondazione Cariplo
ID : ANR-10-LABX-0001-01
Références
J Physiol Sci. 2013 Nov;63(6):445-55
pubmed: 24158847
Chemosphere. 2013 May;91(8):1123-9
pubmed: 23399309
World J Gastroenterol. 2014 Jul 7;20(25):8119-29
pubmed: 25009384
World J Gastroenterol. 2016 Jul 14;22(26):6016-26
pubmed: 27468193
PLoS One. 2019 Mar 21;14(3):e0214159
pubmed: 30897184
Food Chem. 2019 Feb 15;274:642-650
pubmed: 30372989
Crit Rev Food Sci Nutr. 2020 Jan 25;:1-12
pubmed: 31983216
Obes Facts. 2015;8(6):402-24
pubmed: 26641646
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158586
pubmed: 31816412
Front Med (Lausanne). 2019 Sep 13;6:202
pubmed: 31616668
Plant Genome. 2017 Jul;10(2):
pubmed: 28724069
World J Hepatol. 2019 Aug 27;11(8):619-637
pubmed: 31528245
Histol Histopathol. 2009 Jan;24(1):49-60
pubmed: 19012244
Cardiovasc Diabetol. 2016 Aug 25;15(1):119
pubmed: 27562094
Metabolism. 2008 Aug;57(8):1071-7
pubmed: 18640384
Contrib Nephrol. 2011;170:28-35
pubmed: 21659755
Int J Vitam Nutr Res. 1999 Nov;69(6):403-11
pubmed: 10642898
Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):173-5
pubmed: 18990555
Molecules. 2019 Nov 04;24(21):
pubmed: 31689909
Genes Nutr. 2009 Sep;4(3):215-22
pubmed: 19707810
J Cell Sci. 2015 Jul 1;128(13):2350-60
pubmed: 25977473
Int J Mol Med. 2016 Aug;38(2):574-84
pubmed: 27353085
J Biol Chem. 2004 Dec 31;279(53):55633-43
pubmed: 15489227
Hepatology. 2008 May;47(5):1495-503
pubmed: 18220271
Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S14-9
pubmed: 12142955
Cell Res. 2010 Jan;20(1):24-33
pubmed: 19997086
Physiol Mol Biol Plants. 2017 Jan;23(1):197-205
pubmed: 28250595
J Biol Chem. 2014 Oct 3;289(40):27807-13
pubmed: 25112872
Hepatology. 2004 Jul;40(1):185-94
pubmed: 15239102
Food Chem. 2019 Aug 15;289:56-64
pubmed: 30955649
Br J Nutr. 2018 Mar;119(5):479-485
pubmed: 29352819
Crit Rev Food Sci Nutr. 2015;55(8):1137-45
pubmed: 24915347
Br J Nutr. 2007 Oct;98(4):720-6
pubmed: 17666145
Exp Biol Med (Maywood). 2008 Jun;233(6):674-88
pubmed: 18408140
Dig Liver Dis. 2010 May;42(5):320-30
pubmed: 20207596
PLoS One. 2009 Jun 26;4(6):e6066
pubmed: 19557132
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
PLoS One. 2012;7(12):e51847
pubmed: 23300567
Am J Clin Nutr. 2004 Mar;79(3):390-5
pubmed: 14985212
Oxid Med Cell Longev. 2019 Feb 12;2019:9783429
pubmed: 30891116
J Clin Invest. 2004 Dec;114(12):1752-61
pubmed: 15599400
Data Brief. 2019 Oct 07;27:104612
pubmed: 31667322